METHODS OF USING SDF-1 (CXCL12) AS A DIAGNOSTIC AND MESENCHYMAL STEM CELL (MULTIPOTENT STROMAL CELL)-SPECIFIC THERAPEUTIC BIOMARKER FOR THE TREATMENT OF KIDNEY INJURY AND OTHER MAJOR ORGANS

摘要

This application describes the detection and diagnosis of kidney pathology including acute kidney injury by the detection of changes in the amounts of biomarkers in the urine of patients. These biomarkers include stromal derived factor (SDF-1 or CXCL12).